Introduction
A parental history of premature cardiovascular disease (pCVD) confers an increased risk for clinical CVD development in offspring independently of heritable traditional risk factors. 1 However, it is unclear if cumulative exposure to risk factors over young adulthood attenuates the observed association between a parental history of pCVD and risk for CVD events in offspring. Furthermore, it is unclear if these associations are manifest in younger adulthood in terms of subclinical atherosclerosis. Interestingly, risks for subclinical atherosclerosis associated with a parental history of pCVD may vary by race. 2, 3 Likewise, differential risks for CVD in offspring associated with maternal or paternal pCVD history may exist. 4 The young patient with a family history of pCVD can present a clinical dilemma for the clinician. Due to the well-documented associations of coronary artery calcium (CAC) and carotid artery intima-media thickness (IMT) with future CVD events, the assessment of subclinical atherosclerosis, in conjunction with a thorough assessment of traditional CVD risk factors, may be helpful in terms of patient risk stratification for future CVD events. 5, 6 The biracial CARDIA cohort provides a unique opportunity to examine the association of a parental history of pCVD with subclinical atherosclerosis in the context of longitudinal risk factor levels over 20 years in white and black participants in their third and fourth decade of life, when atherosclerosis often begins. In this study we sought to: (1) investigate associations between any parental history of pCVD and CAC and carotid IMT; (2) assess the effect of race on the direction and magnitude of this association; (3) determine associations with CAC and carotid IMT between participants with a maternal or paternal history of CVD; and (4) determine whether adjustment for average risk factors over 20 years of follow up attenuates the association of parental history with CAC and carotid IMT by race.
Methods

Study sample and inclusion and exclusion criteria
CARDIA is a longitudinal, community-based cohort of 5115 black and white men and women who were enrolled at 18-30 years of age in 1985-86. Participating field centres included: Kaiser Permanente, Oakland, CA, USA; Northwestern University, Chicago, IL, USA; University of Alabama in Birmingham, AL, USA, and The University of Minnesota, Minneapolis, MN, USA. The CARDIA study was approved by the institutional review boards of all participating centres.
Thus far, the cohort has been followed through and beyond a year-20 exam. At baseline, the sample was population based and approximately equally divided by sex, race, and educational status. At year 20, CAC scanning and IMT measurements were performed. All participants with parental history survey data at years 0, 5, and 10 and CAC score data at year 20 or IMT at year 20 were included. Participants were excluded if they did not report parental history data, if parental history of CVD became negative on repeat assessment, if they were missing covariate data, or if they were missing IMT or CAC data.
A total of 3548 participants attended the year-0 and year-20 examinations; 722 patients were excluded for either missing parental history data, or parental history data that became negative on repeat measurement. Of the participants excluded for missing parental history data, 59% were black and 41% were white. An additional 543 participants were excluded due to missing covariates or missing CAC or IMT values at year 20.
Parental history ascertainment and risk factor measurement
Participants were administered family history questionnaires at examination in years 0, 5, and 10. At the year-0 examination, participants were asked if there was a history of 'heart attack' or 'stroke' in their mother or father. If they answered 'yes' to either question they were asked at what age it occurred. Participants were also asked if the parent was living; if not, separate fields inquired if 'heart attack' or 'stroke' were the cause of death.
Age, sex, race, and smoking status were obtained from self-report. Body mass index (BMI) was calculated as the weight in kilograms divided by the square of the height in metres. Blood pressure was measured three times by random zero sphygmomanometer, and the mean of the second and third measurements was used. Total cholesterol and high-density lipoprotein cholesterol were measured from serum from a fasting blood draw that was separated and plasma frozen to À70 C prior to analysis in a central laboratory. lowdensity lipoprotein cholesterol was estimated by using the Friedwald equation. 7 Glomerular filtration rate was calculated using the Modification of Diet in Renal Disease Study formula. 8 Diabetes mellitus was determined by self-report or the presence of diabetes medications. Medication history was determined by selfreport, medications lists were reviewed, and medications were coded as antihypertensive and lipid lowering medications. Income and educational status were determined by self-report.
Measurement of CAC
Participants underwent computed tomography (CT) scanning with electron beam CT (Imatron C-150) or multidetector CT (GE Lightspeed or Siemens VZ) during their year-20 exam. All participants had two sets of images obtained, with 45-55 (depending on heart size) sequential 3-mm transverse images from the aortic root to the cardiac apex acquired. All images were captured during ventricular diastole (80% of the R-R interval). A CAC focus was defined as a region of four or more adjacent pixels with a CT number greater than 130 Houndsfield units. A total CAC score was computed by summing the Agatston score for each coronary artery and across all coronary arteries. 9 The mean of the scores from each scan was the final CAC score. CAC was defined as present if the score was greater than zero. Scans from participants with at least one non-zero score were reviewed by an expert investigator blinded to the scan scores.
Measurement of IMT
Ultrasound studies were acquired according to a standard protocol using a GE-Logiq-700 (Issaquoah Ill). A high-resolution M12L transducer operating at a frequency of 13 MHz was used to image the common carotid artery. An operating frequency of 9 MHz was used to image the internal carotid artery and the carotid bulb. Image acquisition was made at end diastole. 10 Measurements of the composite IMT were used in the analysis. The composite IMT measurement is an average of all available values from the common carotid artery, internal carotid artery, and the carotid bulb IMT.
Endpoints of interest
Our primary endpoints of interest were the prevalence of CAC score >0 at year 20, prevalence of IMT >90% at year 20, and continuous IMT measurements in CARDIA participants.
Statistical analysis
We focused on parental history of pCVD (<65 years old in the mother or <55 years old in the father) and stratified participants into the following groups: maternal history of pCVD, paternal history of pCVD, or any parental history of pCVD. Any parental history included participants with either maternal or paternal history or both. All analyses used a common referent group consisting of those with no history of either maternal or paternal pCVD. The associations between a parental history of pCVD and categorical subclinical atherosclerosis (CAC >0 and IMT >90%) were examined using logistic regression modelling. We assessed for first-order interactions between parental history of pCVD, race, and subclinical atherosclerosis using multiplicative interaction terms. Significant interaction terms were observed, therefore our analysis was stratified by race. The prevalence of CAC >0 and carotid IMT >90% were compared across strata using chisquared tests. Logistic regression models were fitted unadjusted, and adjusted in three separate models.
Model 1 was run unadjusted, model 2 was adjusted for age and sex; model 3 was adjusted for sex, age, body mass index, blood pressure; total cholesterol, high-density lipoprotein cholesterol, income, glomerular filtration rate, use of lipid therapy, use of antihypertensive medication, educational status, income, presence of diabetes mellitus, and tobacco use status. For continuous variables, we used the average of all available measurements from exam years 0-20 provided a participant had information from year 0, year 20, and at least one interim exam. The categorical variables use of lipid therapy, use of antihypertensive medication, educational status, income, presence of diabetes mellitus, and tobacco use status were assigned at year-20 data. We also utilized adjusted linear regression modelling using IMT as continuous variables. All analyses were performed using SAS version 9.1 (SAS Institute, Cary, NC, USA). A p value <0.05 was considered statistically significant.
Results
Baseline characteristics
We included 2283 participants in the final analysis; there were 109 participants with maternal-only, 197 with paternal-only, and 18 with biparental history of pCVD, yielding a total of 324 with any parental history of pCVD. Compared to participants with no parental history of pCVD (n ¼ 1959), those with any parental history of pCVD were older, had higher blood pressure, body mass index, total cholesterol, and prevalence of diabetes mellitus and antihypertension medication use. There was a higher proportion of women and a lower proportion of white participants in the any parental history of pCVD group. Longitudinal average risk factor characteristics for subclinical atherosclerosis covariates are presented in Table 1 .
Measures of subclinical atherosclerosis in participants with maternal, paternal, and any parental history of pCVD
Unadjusted comparisons of the prevalence of CAC >0, IMT >90%, and IMT values (mm) between different pCVD parental history groups are presented in Table 2 . Among participants with paternal and any parental pCVD, the proportion with CAC >0 was significantly higher compared with those who had no parental history of pCVD; there was no significant difference found between the maternal pCVD group and the referent. Composite IMT was significantly greater in the maternal and any parental groups. However, the proportion of participants with IMT >90% was greater in the paternal and any parental pCVD groups.
Measures of subclinical atherosclerosis in participants with maternal, paternal, and any parental history of pCVD when stratified by race There was evidence for a significant interaction between any parental and paternal history of pCVD and race in association with CAC >0 (p ¼ 0.03 and 0.01 respectively), and composite IMT >90% (p ¼ 0.047 for any parental pCVD group). Thus, data are presented stratified by race (Table 3) . White participants with a paternal and any parental history of pCVD had significantly increased odds of CAC >0 and composite IMT >90% in unadjusted and fully adjusted models. Conversely, there were no significant associations observed between a parental history of pCVD with CAC >0 or IMT >90% in black participants. Among whites, these associations were demonstrated in participants with any parental history of pCVD; however, the odds ratio was lower and largely driven by the paternal contribution, and the strength of the association was partially attenuated in fully adjusted models. 
Discussion
Among a biracial cohort of younger adults, we observed that white participants with paternal and any parental history of pCVD had a higher odds of having CAC >0 in middle age. This association was largely driven by the association of CAC >0 with a reported paternal history of pCVD, and the strength of the association was only partially attenuated by adjustment for long-term average risk factor levels from young adulthood to middle age. Logistic regression models did not demonstrate an association between a parental history of pCVD and CAC or carotid IMT >90% in black participants. These data support the previous findings that a parental history of pCVD has an independent effect that increases the probability of developing subclinical atherosclerosis in offspring; however, this may not be true of black participants in their fifth decade. Associations between a history of parental premature coronary heart disease and CAC in offspring have been observed in multiple cohorts. [11] [12] [13] [14] For example, in the significantly older MESA cohort, white, black, Hispanic, and Chinese American participants with a parental history of premature coronary heart disease had a significantly increased odds of CAC >0. 15 However, as stated above, we did not find an association between parental history of pCVD and CAC in black participants in our study. This may be an artefact of misclassification of parental history due to the younger age of our cohort, or it may imply racespecific pathophysiological differences in the development of atherosclerosis in the young which have been previously described in the Pathological Determinants of Atherosclerosis in Youth Cohort. 16 In an analysis of year-15 data from CARDIA, Fornage et al. 3 demonstrated an association between a parental history of myocardial infarction and stroke and CAC. The associations were race-specific, as black participants had a significant adjusted association between a paternal history of stroke and white participants had a significant adjusted association between a paternal history of myocardial infarction and CAC. Similarly to our data, the associations were largely driven by the paternal history of CVD. Our study and the Fornage study differ in several important ways; notably the exposure, outcome, and analysis are different. We used family history data from years 0, 5, and 10 in our analysis; thus, the average age of parents having events was likely to be greater in our study as Fornage included family history data from years 0 and 5 only. Furthermore, we used a composite of stroke and coronary heart disease events in the parents to define our family history exposure; Fornage used family history of coronary heart disease and stoke as separate exposures. CAC and carotid IMT from year 20 were the outcomes in our analysis. Thus, we are testing the association between our composite family history and carotid and coronary subclincal atherosclerosis in a population that is approximately 5 years older than the Fornage study, which looked at the association between family history and exclusively CAC at year 15. Lastly, we adjusted for average risk factors over 20 years of follow up; this was not performed in the Fornage study. 3 Our results are similar to several other studies that have demonstrated an association between parental CVD and increased carotid IMT. In the older, predominantly white Framingham Offspring Cohort, Wang et al. 17 demonstrated an association between a parental history of pCVD and carotid IMT. Notably, there was no difference in internal carotid IMT between maternal and paternal history of pCVD groups. A race-specific association was detected by Bensen et al. 2 in the Atherosclerosis at Risk in Communities Studies, as whites with an elevated Family Risk Score had a higher odds of increased carotid IMT. However, similarly to our results, no significant association was detected in black participants. 2 Given the association of parental history of pCVD with offspring CVD events in both whites and blacks, individuals with a parental history of pCVD likely have increased predilection for the development of early subclinical atherosclerosis and increased overall burden of atherosclerosis. 6 As such, it is surprising that the increased likelihood of CAC and carotid IMT was not observed in black participants or participants with a maternal history of pCVD. In the present study this race-specific association may be partially explained by the lower prevalence of CAC in blacks when compared to whites, which has been observed in other cohorts. 18 Furthermore, the lack of an association may be due to decreased power to detect associations given the smaller sample size of the respective race subgroups or due to misclassification of self-reported parental history in either group. It is also possible that CAC and carotid IMT do not associate with parental history in these groups due to differences in the rate and/or timing of the development of subclinical atherosclerosis in blacks and whites. For example, it may be that CAC and increased carotid IMT do not become prevalent until the sixth decade or later in blacks. Specifically in regards to CAC, perhaps differences in CAC prevalence between blacks and whites may not be due to differences in the total burden of atherosclerosis per se, but may be partially explained by differences in the degree of calcification of atherosclerosis. 19 Alternatively, it may be that the burden of atherosclerosis may in fact be less, but differences in plaque stability, platelet function, thrombosis, and inflammation may differ and explain some of the risk for CVD events in blacks with a parental history of pCVD. Clinically, these data suggest that the use of subclinical atherosclerosis to improve risk assessment in black patients in their fifth decade with family histories of pCVD may be limited. If the overall prevalence of positive CAC is low in black patients then the number needed to screen may be unacceptably high which would severely limit the utility of CAC testing in this population.
Our study benefited from a well-phenotyped cohort with repeated risk factor measurements over 20 years, which allowed for more complete adjustment, particularly for risk factor burden over time. Average blood pressure values from repeated measures have been shown to be more heritable than single measurements; therefore, repeated measures may more completely account for confounding from otherwise unmeasured inherited factors and yield a more accurate estimate of the association between CAC and a history of parental pCVD. 7 There are several limitations to our current study. First, parental history was obtained from self-report, which has been shown to have a positive predictive value of only 70% when compared with physician adjudication. 20 Regardless, most community-based observation cohorts and clinicians determine family history from self-report. Thus, these data help describe the utility of family history information obtained during a clinical interview for predicting the likelihood of subclinical atherosclerosis. Second, some pCVD events may not have been captured at year 10, since all parents of year-10 examinees may not have been old enough to have pCVD events by that time. We expect this would have led to an underestimation of parental pCVD which would bias our findings towards the null. Therefore, this may explain the lack of a significant association between a maternal history of pCVD and subclinical atherosclerosis observed in this study. Third, CAC may not capture early, non-calcified forms of atherosclerosis which could result in an underestimate of the association between family history of pCVD and subclinical atherosclerosis.
In conclusion, CARDIA participants in their fifth decade with a parental history of pCVD had an increased odds for the presence of CAC and composite carotid IMT >90% in whites; this association was likely driven mostly by the contribution from paternal history. The risks attributable to a parental history are partially attenuated by adjustment for long-term risk factor levels measured over 20 years from young adulthood to middle age. Furthermore, there appear to be race-specific associations between a parental history of pCVD, CAC, and composite carotid IMT >90% in CARDIA participants.
